Article

Dallas NewsDallas News on 2022-06-15 15:01

Fort Worth biopharma Nacuity lands $16.5 million in eye disease research funding

Nacuity is in the clinical stages of developing treatments for retinitis pigmentosa, a group of genetic eye diseases and cataracts caused by oxidative ...

Related news